Status:
RECRUITING
Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.
Lead Sponsor:
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Conditions:
Alzheimer Disease
Mild Cognitive Impairment
Eligibility:
All Genders
45+ years
Brief Summary
Alzheimer's disease (AD) is the leading cause of dementia and its prevalence is estimated to exceed 100 million affects by 2050, becoming the main public health problem worldwide. AD is considered a c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men and women between 45 and 74 years at the time of inclusion in the 45-65/FPM2012 study or older than 45 for persons who have not previously participated in 45-65/FPM2012.
- Cognitively healthy persons with SCD, as well as people with MCI and mild dementia.
- Participation of a relative to perform the subjective memory complaint and clinical interview.
- Exclusion criteria:
- Any significant systemic illness or unstable medical condition which could lead to difficulty complying with the protocol.
- Any significant disorder that could course with cognitive impairment that is not related to AD.
- Family history of monogenic AD.
Exclusion
Key Trial Info
Start Date :
February 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03851523
Start Date
February 12 2018
End Date
December 31 2027
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barcelonabeta Brain Research Center
Barcelona, Catalonia, Spain, 08005